Recent Finacing
Recent Raise
Axerion Therapeutics develops and commercializes Yale‑licensed therapeutics for neurological injuries and diseases, including Aβ‑PrP binding blockers for Alzheimer’s and a Nogo decoy receptor for spinal cord recovery.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor